Hall Richard J, Draper Jenny L, Nielsen Fiona G G, Dutilh Bas E
Institute of Environmental Science and Research, National Centre for Biosecurity and Infectious Disease, Upper Hutt New Zealand.
Ministry for Primary Industries Animal Health Laboratory, National Centre for Biosecurity and Infectious Disease, Upper Hutt New Zealand.
Front Microbiol. 2015 Mar 25;6:224. doi: 10.3389/fmicb.2015.00224. eCollection 2015.
Powered by recent advances in next-generation sequencing technologies, metagenomics has already unveiled vast microbial biodiversity in a range of environments, and is increasingly being applied in clinics for difficult-to-diagnose cases. It can be tempting to suggest that metagenomics could be used as a "universal test" for all pathogens without the need to conduct lengthy serial testing using specific assays. While this is an exciting prospect, there are issues that need to be addressed before metagenomic methods can be applied with rigor as a diagnostic tool, including the potential for incidental findings, unforeseen consequences for trade and regulatory authorities, privacy and cultural issues, data sharing, and appropriate reporting of results to end-users. These issues will require consideration and discussion across a range of disciplines, with inclusion of scientists, ethicists, clinicians, diagnosticians, health practitioners, and ultimately the public. Here, we provide a primer for consideration on some of these issues.
受新一代测序技术近期进展的推动,宏基因组学已揭示了一系列环境中丰富的微生物多样性,并且越来越多地应用于临床中难以诊断的病例。有人可能会认为宏基因组学可以用作针对所有病原体的“通用检测方法”,而无需使用特定检测方法进行冗长的系列检测。虽然这是一个令人兴奋的前景,但在宏基因组学方法能够作为诊断工具严格应用之前,仍有一些问题需要解决,包括偶然发现的可能性、对贸易和监管机构的意外影响、隐私和文化问题、数据共享以及向最终用户恰当报告结果等。这些问题需要跨学科进行考量和讨论,涉及科学家、伦理学家、临床医生、诊断专家、健康从业者,最终还包括公众。在此,我们提供一份关于其中一些问题的思考入门指南。